348 related articles for article (PubMed ID: 18753622)
41. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
42. The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer.
Zhuang J; Jones A; Lee SH; Ng E; Fiegl H; Zikan M; Cibula D; Sargent A; Salvesen HB; Jacobs IJ; Kitchener HC; Teschendorff AE; Widschwendter M
PLoS Genet; 2012 Feb; 8(2):e1002517. PubMed ID: 22346766
[TBL] [Abstract][Full Text] [Related]
43. A microarray-based DNA methylation study of glioblastoma multiforme.
Martinez R; Martin-Subero JI; Rohde V; Kirsch M; Alaminos M; Fernandez AF; Ropero S; Schackert G; Esteller M
Epigenetics; 2009 May; 4(4):255-64. PubMed ID: 19550145
[TBL] [Abstract][Full Text] [Related]
44. Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation.
Fouse SD; Shen Y; Pellegrini M; Cole S; Meissner A; Van Neste L; Jaenisch R; Fan G
Cell Stem Cell; 2008 Feb; 2(2):160-9. PubMed ID: 18371437
[TBL] [Abstract][Full Text] [Related]
45. Beyond the island: epigenetic biomarkers of colorectal and prostate cancer.
Savio AJ; Bapat B
Methods Mol Biol; 2015; 1238():103-24. PubMed ID: 25421657
[TBL] [Abstract][Full Text] [Related]
46. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.
Ohm JE; McGarvey KM; Yu X; Cheng L; Schuebel KE; Cope L; Mohammad HP; Chen W; Daniel VC; Yu W; Berman DM; Jenuwein T; Pruitt K; Sharkis SJ; Watkins DN; Herman JG; Baylin SB
Nat Genet; 2007 Feb; 39(2):237-42. PubMed ID: 17211412
[TBL] [Abstract][Full Text] [Related]
47. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.
Yu J; Yu J; Rhodes DR; Tomlins SA; Cao X; Chen G; Mehra R; Wang X; Ghosh D; Shah RB; Varambally S; Pienta KJ; Chinnaiyan AM
Cancer Res; 2007 Nov; 67(22):10657-63. PubMed ID: 18006806
[TBL] [Abstract][Full Text] [Related]
48. Altered DNA methylation landscapes of polycomb-repressed loci are associated with prostate cancer progression and ERG oncogene expression in prostate cancer.
Kron K; Trudel D; Pethe V; Briollais L; Fleshner N; van der Kwast T; Bapat B
Clin Cancer Res; 2013 Jul; 19(13):3450-61. PubMed ID: 23549870
[TBL] [Abstract][Full Text] [Related]
49. Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.
Kalari S; Pfeifer GP
Adv Genet; 2010; 70():277-308. PubMed ID: 20920752
[TBL] [Abstract][Full Text] [Related]
50. Polycomb repressive complex 2 epigenomic signature defines age-associated hypermethylation and gene expression changes.
Dozmorov MG
Epigenetics; 2015; 10(6):484-95. PubMed ID: 25880792
[TBL] [Abstract][Full Text] [Related]
51. Androgen-induced Epigenetic Profiles of Polycomb and Trithorax Genes in Prostate Cancer Cells.
Wang S; Tailor K; Kwabi-Addo B
Anticancer Res; 2020 May; 40(5):2559-2565. PubMed ID: 32366400
[TBL] [Abstract][Full Text] [Related]
52. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
[TBL] [Abstract][Full Text] [Related]
53. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
54. Epigenetic dysregulation of key developmental genes in radiation-induced rat mammary carcinomas.
Daino K; Nishimura M; Imaoka T; Takabatake M; Morioka T; Nishimura Y; Shimada Y; Kakinuma S
Int J Cancer; 2018 Jul; 143(2):343-354. PubMed ID: 29435983
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.
Bracken AP; Dietrich N; Pasini D; Hansen KH; Helin K
Genes Dev; 2006 May; 20(9):1123-36. PubMed ID: 16618801
[TBL] [Abstract][Full Text] [Related]
56. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
[TBL] [Abstract][Full Text] [Related]
57. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
58. DNA binding by polycomb-group proteins: searching for the link to CpG islands.
Owen BM; Davidovich C
Nucleic Acids Res; 2022 May; 50(9):4813-4839. PubMed ID: 35489059
[TBL] [Abstract][Full Text] [Related]
59. Repression of E-cadherin by the polycomb group protein EZH2 in cancer.
Cao Q; Yu J; Dhanasekaran SM; Kim JH; Mani RS; Tomlins SA; Mehra R; Laxman B; Cao X; Yu J; Kleer CG; Varambally S; Chinnaiyan AM
Oncogene; 2008 Dec; 27(58):7274-84. PubMed ID: 18806826
[TBL] [Abstract][Full Text] [Related]
60. SIRT1 affects DNA methylation of polycomb group protein target genes, a hotspot of the epigenetic shift observed in ageing.
Wakeling LA; Ions LJ; Escolme SM; Cockell SJ; Su T; Dey M; Hampton EV; Jenkins G; Wainwright LJ; McKay JA; Ford D
Hum Genomics; 2015 Jun; 9(1):14. PubMed ID: 26104761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
